Zhongxin.com Lanzhou, October 11 (Nanru Zhuoma) Liu Zhanglin, vice president of the China Chamber of Commerce for Import and Export of Medicines and Health Products, said in an interview with China News Service on the 11th in Gansu, Gansu, that in the case of a decline in import and export trade The export trade of Chinese medicine has become "outstanding". From January to July this year, the export of Chinese medicine has increased by about 10%.
On the same day, the “One Belt and One Road” International Cooperation Forum for Chinese Medicine and the “Belt and Road” Chinese Ambassadors in China were held in Qianxi County, Gansu Province. Liu Zhanglin analyzed the status of Chinese medicine import and export at the meeting. He told reporters that with the construction of the “Belt and Road”, Chinese medicine has occupied an increasingly important position in international trade. In the first half of this year, Chinese medicine exports 154 countries and regions. The Asian region is still the main market for Chinese medicine exports. Among them, Hong Kong, China is the first market for Chinese medicine exports in the Mainland, with exports in the first half of the year alone of US$300 million.
Liu Zhanglin said that Japan, Malaysia, South Korea and Indonesia are also the main target markets for Chinese medicine exports, while the United States is the third largest market for Chinese medicine exports, and has maintained a relatively high growth rate in recent years. According to the statistics of the China Chamber of Commerce for Import and Export of Medicines and Health Products, in the first half of this year, China exported US$270 million to the United States, up 17.2% year-on-year, accounting for 14.1% of Chinese medicine exports. The Chinese medicine products exported to the US are mainly plant extracts, accounting for It reached 78.2%.
"The Belt and Road countries have a good foundation of Chinese medicine culture, and they have a high degree of acceptance of Chinese medicine, and these countries account for more than 50% of the total import and export of Chinese medicine." Liu Zhanglin analyzed that the overall demand for Chinese medicine in the world is growing, with an average increase of about 5% per year. Among them, ginseng and medlar are the most popular Chinese herbal medicines in foreign countries, in addition to Codonopsis, Angelica, Rehmannia, Chrysanthemum and so on.
In 2014 and 2015, the import and export volume of traditional Chinese medicine in Gansu increased by 35% and 76% respectively. Liu Zhanglin believes that in the context of the “Belt and Road”, Gansu, as the birthplace of Chinese medicine culture, has great foreign trade potential. He said that Gansu is a local medicinal planting area with advantages in medicinal materials trade and storage. In addition, there is a geographical advantage. Gansu is on the main road of the Silk Road and is the frontier position to open to the west.
For Chinese medicine to go abroad and open the biggest obstacles in the international market, Liu Zhanglin admits that the first is the difficulty of regulations and registration, and the second is how to expand the marketing channels after the export of Chinese medicine.